Acromegaly: Difference between revisions
No edit summary |
No edit summary |
||
Line 44: | Line 44: | ||
IGF-1, the target molecule of GH, enables many of the growth-promoting actions of GH; GH itself is also a regulator of mineral, lipid, and carbohydrate metabolism.<ref name="Shlomo">6.</ref> Therefore the elevated levels of GH and IGF-1 which are characteristic of acromegaly excessive soft tissue growth, swelling of internal organs, and musculoskeletal, neurological, and metabolic comorbidities.<ref name="Shlomo">6.</ref> <br> | IGF-1, the target molecule of GH, enables many of the growth-promoting actions of GH; GH itself is also a regulator of mineral, lipid, and carbohydrate metabolism.<ref name="Shlomo">6.</ref> Therefore the elevated levels of GH and IGF-1 which are characteristic of acromegaly excessive soft tissue growth, swelling of internal organs, and musculoskeletal, neurological, and metabolic comorbidities.<ref name="Shlomo">6.</ref> <br> | ||
Cardiovascular:<ref name="Vance">1.</ref><ref name="Cordero">2.</ref><ref name="Reid">5.</ref><ref name="Shlomo">6.</ref> | Cardiovascular:<ref name="Vance">1.</ref><ref name="Cordero">2.</ref><ref name="Reid">5.</ref><ref name="Shlomo">6.</ref> | ||
*Hypertension | *Hypertension | ||
*Arrhythmias | *Arrhythmias | ||
*Valvulopathy | *Valvulopathy | ||
*Cardiomyopathy | *Cardiomyopathy | ||
*Hypertrophy (biventricular or asymmetric septal) | *Hypertrophy (biventricular or asymmetric septal) | ||
*Congestive heart failure | *Congestive heart failure | ||
<br> | |||
Pulmonary:<ref name="Vance">1.</ref><ref name="Cordero">2.</ref><ref name="Reid">5.</ref><ref name="Shlomo">6.</ref> | |||
*Obstructive sleep apnea | |||
*Macroglossia | |||
*Upper airway obstruction | |||
*Ventilatory dysfunction | |||
*Upper airway obstruction | |||
<br> | |||
Metabolic:<ref name="Vance">1.</ref><ref name="Cordero">2.</ref><ref name="Shlomo">6.</ref> | |||
*Insulin resistance | |||
*Impaired glucose metabolism | |||
*Diabetes mellitus | |||
* | |||
* | Visceral:<ref name="Vance">1.</ref><ref name="Shlomo">6.</ref> | ||
* | |||
* | *Organ enlargement | ||
*Colon polyps | |||
*Fluid retention | |||
*Renal failure | |||
Musculoskeletal:<ref name="Cordero">2.</ref> | |||
* | *Arthropathy/osteoarthritis | ||
* | *Carpal tunnel syndrome | ||
* | *Osteopenia | ||
== Medications == | == Medications == |
Revision as of 04:52, 19 March 2011
Original Editors - Alex Kent from Bellarmine University's Pathophysiology of Complex Patient Problems project.
Lead Editors - Your name will be added here if you are a lead editor on this page. Read more.
Definition/Description
[edit | edit source]
Acromegaly is a rare systemic disease which affects the entire body.[1] It is characterized by a hypersecretion of growth hormone (GH) which the body is unable to regulate.[2] GH facilitates growth of muscles, internal organs, and bones, as well as stimulating secretion of its target hormone insulin-like growth factor 1 (IGF-1).[1] ,[3] The extremely high levels of GH and IGF-1 which typify acromegaly cause tissue enlargement and metabolic changes that result in visible deformity as well as an increase in mortality.[2][4] The disease often begins between the ages of 30 and 50, and has an insidious onset and slow progression, often delaying diagnosis until later stages of the disease.[2][3]
Prevalence[edit | edit source]
- The prevalence of acromegaly is approximately 40-70 cases per million persons.[2][4]
- However, new research suggests that the prevalence may be as high as 77 cases per million persons.[4]
- The annual incidence of acromegaly is approximately is 3-4 new cases per million persons.[4]
Characteristics/Clinical Presentation[edit | edit source]
Acromegaly affects many of the body's systems, and various signs and symptoms develop over a period of several years.[5] They range from subtle changes to notable disfigurement.[2]
Clinical Presentation[2][3][5][6]:
- Hand and foot enlargement
- Hyperhydrosis- increased perspiration
- Increased skin thickness
- Darkening and thickening of body hair
- Frontal skull bossing- an abnormally heavy brow and prominent forehead
- Widening of the maxilla accompanied by separation of the teeth
- Jaw malocclusion and overbite
- Soft tissue enlargement
- Skeletal overgrowth and thickening causing many areas to appear swollen
- Deep and husky voice due to thickening of cartilage in the larynx
- Ventilatory dysfunction
- Weight gain
- Joint pain
- Sleep apnea
- Acne
- Vision problems
Associated Co-morbidities[edit | edit source]
IGF-1, the target molecule of GH, enables many of the growth-promoting actions of GH; GH itself is also a regulator of mineral, lipid, and carbohydrate metabolism.[6] Therefore the elevated levels of GH and IGF-1 which are characteristic of acromegaly excessive soft tissue growth, swelling of internal organs, and musculoskeletal, neurological, and metabolic comorbidities.[6]
- Hypertension
- Arrhythmias
- Valvulopathy
- Cardiomyopathy
- Hypertrophy (biventricular or asymmetric septal)
- Congestive heart failure
- Obstructive sleep apnea
- Macroglossia
- Upper airway obstruction
- Ventilatory dysfunction
- Upper airway obstruction
- Insulin resistance
- Impaired glucose metabolism
- Diabetes mellitus
- Organ enlargement
- Colon polyps
- Fluid retention
- Renal failure
Musculoskeletal:[2]
- Arthropathy/osteoarthritis
- Carpal tunnel syndrome
- Osteopenia
Medications[edit | edit source]
add text here
Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]
add text here
Etiology/Causes[edit | edit source]
add text here
Systemic Involvement[edit | edit source]
add text here
Medical Management (current best evidence)[edit | edit source]
add text here
Physical Therapy Management (current best evidence)[edit | edit source]
add text here
Alternative/Holistic Management (current best evidence)[edit | edit source]
add text here
Differential Diagnosis[edit | edit source]
add text here
Case Reports/ Case Studies[edit | edit source]
add links to case studies here (case studies should be added on new pages using the case study template)
Resources
[edit | edit source]
add appropriate resources here
Recent Related Research (from Pubmed)[edit | edit source]
see tutorial on Adding PubMed Feed
Extension:RSS -- Error: Not a valid URL: Feed goes here!!|charset=UTF-8|short|max=10
References[edit | edit source]
see adding references tutorial.
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1. Vance M. Acromegaly: a fascinating pituitary disorder. Neurosurg Focus 2010;29(4):1. Cite error: Invalid
<ref>
tag; name "Vance" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Vance" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Vance" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Vance" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Vance" defined multiple times with different content - ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2. Cordero RA, Barkan AL. Current diagnosis of acromegaly. Rev Endocr Metab Disord 2008;9:13-19. Cite error: Invalid
<ref>
tag; name "Cordero" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Cordero" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Cordero" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Cordero" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Cordero" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Cordero" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Cordero" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Cordero" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Cordero" defined multiple times with different content - ↑ 3.0 3.1 3.2 3.Merck Manual Home Edition. Acromegaly and gigantism: pituitary gland disorders. http://www.merckmanuals.com/home/print/sec13/ch162e.html (Accessed March 11 2011). Cite error: Invalid
<ref>
tag; name "Merck" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Merck" defined multiple times with different content - ↑ 4.0 4.1 4.2 4.3 4.Fleseriu M, Delashaw JB, Cook DM. Acromegaly: a review of current medical therapy and new drugs on the horizon. Neurosurg Focus 2010;29(4):E15. Cite error: Invalid
<ref>
tag; name "Fleseriu" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Fleseriu" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Fleseriu" defined multiple times with different content - ↑ 5.0 5.1 5.2 5.3 5. Reid TJ, Post KD, Bruce JN, Kanibir MN, Reyes-Vidal CM, Freda PU. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clinical Endocrinology 2010;72:203-208. Cite error: Invalid
<ref>
tag; name "Reid" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Reid" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Reid" defined multiple times with different content - ↑ 6.0 6.1 6.2 6.3 6.4 6.5 6.6 6.Melmed S. Acromegaly pathogenesis and treatment. J. Clin. Invest 2009;119:3189-3202. Cite error: Invalid
<ref>
tag; name "Shlomo" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Shlomo" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Shlomo" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Shlomo" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Shlomo" defined multiple times with different content Cite error: Invalid<ref>
tag; name "Shlomo" defined multiple times with different content